TW200635941A - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- TW200635941A TW200635941A TW094138749A TW94138749A TW200635941A TW 200635941 A TW200635941 A TW 200635941A TW 094138749 A TW094138749 A TW 094138749A TW 94138749 A TW94138749 A TW 94138749A TW 200635941 A TW200635941 A TW 200635941A
- Authority
- TW
- Taiwan
- Prior art keywords
- chemical compounds
- sarsasapogenin
- solvated
- crystalline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424528A GB0424528D0 (en) | 2004-11-05 | 2004-11-05 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200635941A true TW200635941A (en) | 2006-10-16 |
Family
ID=33523268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094138749A TW200635941A (en) | 2004-11-05 | 2005-11-04 | Chemical compounds |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080194530A1 (zh) |
EP (2) | EP2479183A3 (zh) |
JP (1) | JP2008519020A (zh) |
KR (1) | KR20070089798A (zh) |
CN (2) | CN102219826A (zh) |
AU (1) | AU2005300348A1 (zh) |
BR (1) | BRPI0517648A (zh) |
CA (1) | CA2584676A1 (zh) |
GB (1) | GB0424528D0 (zh) |
IL (1) | IL182879A0 (zh) |
MX (1) | MX2007005473A (zh) |
NO (1) | NO20072794L (zh) |
RU (1) | RU2007119611A (zh) |
SG (1) | SG158068A1 (zh) |
TW (1) | TW200635941A (zh) |
WO (1) | WO2006048665A2 (zh) |
ZA (1) | ZA200703630B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010084356A1 (en) | 2009-01-24 | 2010-07-29 | Phytopharm Plc | Treatment of neurotrophic factor mediated disorders |
BR112013001422A2 (pt) | 2010-07-20 | 2019-09-24 | Phytopharm Plc | metodo para tratar ou previnir disturbios induzidos por l-dopa, agonista dopamina e/ou acentuador de dopamina em um individuo que necessita dos mesmos, agente, composição, uso de ou mais agentes e metodo para tratar a doença de parkinson |
JP5881525B2 (ja) * | 2011-05-16 | 2016-03-09 | ライオン株式会社 | サポゲニン安定化組成物の製造方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2306635A (en) * | 1940-08-03 | 1942-12-29 | Parke Davis & Co | Method for the preparation of steroidal carbinols |
US2408827A (en) * | 1944-05-15 | 1946-10-08 | Parke Davis & Co | Steroidal compounds and methods for obtaining the same |
US2774714A (en) * | 1952-10-10 | 1956-12-18 | Emanuel B Hershberg | Process for the extraction of sapogenins from plant materials |
US3019220A (en) * | 1958-07-17 | 1962-01-30 | Julian Lab Inc | Isolation of sapogenins |
US4057543A (en) * | 1976-07-01 | 1977-11-08 | G. D. Searle & Co. | Process for the preparation of 17β-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone |
US4680289A (en) | 1985-06-05 | 1987-07-14 | Progenics, Inc. | Treatment of obesity and diabetes using sapogenins |
JPH04230696A (ja) * | 1990-12-28 | 1992-08-19 | Sanwa Shiyouyaku Kk | 新規なステロイド系化合物および制癌剤 |
CN1033754C (zh) * | 1993-05-31 | 1997-01-08 | 上海第二医科大学 | 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法 |
KR100217996B1 (ko) * | 1996-12-23 | 1999-09-01 | 윤종용 | 프린트 헤드의 노즐 간격 보상 장치 및 방법 |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
TR200002774T2 (tr) | 1998-03-26 | 2001-06-21 | Phytopharm Plc | Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri |
GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
AT409100B (de) | 2000-07-24 | 2002-05-27 | Evg Entwicklung Verwert Ges | Vorrichtung zum schweissen einer drahtgittermatte |
GB0107822D0 (en) | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
RU2332999C2 (ru) | 2002-03-27 | 2008-09-10 | ФИТОФАРМ ПиЭлСи | Терапевтические способы и применения сапогенинов и их производных |
-
2004
- 2004-11-05 GB GB0424528A patent/GB0424528D0/en not_active Ceased
-
2005
- 2005-11-04 TW TW094138749A patent/TW200635941A/zh unknown
- 2005-11-04 SG SG200907351-1A patent/SG158068A1/en unknown
- 2005-11-04 KR KR1020077012720A patent/KR20070089798A/ko not_active Application Discontinuation
- 2005-11-04 EP EP11155897.9A patent/EP2479183A3/en not_active Withdrawn
- 2005-11-04 CN CN2011100921741A patent/CN102219826A/zh active Pending
- 2005-11-04 EP EP05799915A patent/EP1809650A2/en not_active Withdrawn
- 2005-11-04 WO PCT/GB2005/004266 patent/WO2006048665A2/en active Application Filing
- 2005-11-04 JP JP2007539637A patent/JP2008519020A/ja active Pending
- 2005-11-04 US US11/667,035 patent/US20080194530A1/en not_active Abandoned
- 2005-11-04 BR BRPI0517648-4A patent/BRPI0517648A/pt not_active IP Right Cessation
- 2005-11-04 RU RU2007119611/04A patent/RU2007119611A/ru not_active Application Discontinuation
- 2005-11-04 CA CA002584676A patent/CA2584676A1/en not_active Abandoned
- 2005-11-04 CN CN200580037705XA patent/CN101068827B/zh not_active Expired - Fee Related
- 2005-11-04 MX MX2007005473A patent/MX2007005473A/es unknown
- 2005-11-04 AU AU2005300348A patent/AU2005300348A1/en not_active Abandoned
-
2007
- 2007-04-30 IL IL182879A patent/IL182879A0/en unknown
- 2007-05-04 ZA ZA200703630A patent/ZA200703630B/xx unknown
- 2007-06-01 NO NO20072794A patent/NO20072794L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2008519020A (ja) | 2008-06-05 |
CN102219826A (zh) | 2011-10-19 |
RU2007119611A (ru) | 2008-12-10 |
CN101068827B (zh) | 2011-06-08 |
GB0424528D0 (en) | 2004-12-08 |
KR20070089798A (ko) | 2007-09-03 |
WO2006048665A2 (en) | 2006-05-11 |
EP1809650A2 (en) | 2007-07-25 |
US20080194530A1 (en) | 2008-08-14 |
NO20072794L (no) | 2007-07-31 |
ZA200703630B (en) | 2009-10-28 |
IL182879A0 (en) | 2007-08-19 |
SG158068A1 (en) | 2010-01-29 |
EP2479183A2 (en) | 2012-07-25 |
MX2007005473A (es) | 2007-05-24 |
CN101068827A (zh) | 2007-11-07 |
WO2006048665A3 (en) | 2006-09-08 |
CA2584676A1 (en) | 2006-05-11 |
EP2479183A3 (en) | 2013-08-28 |
AU2005300348A1 (en) | 2006-05-11 |
BRPI0517648A (pt) | 2008-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200709856B (en) | Fluorene derivatives,compositions containing said derivatives and the use thereof | |
HK1094433A1 (en) | Flocculating agent, method for the production and use thereof | |
HK1093731A1 (en) | Sulfoximine-substituted pyrimidines for use as cdk and/or vegf inhibitors, the production thereof and their use as drugs | |
WO2007078838A3 (en) | Solid biocide composition and sealed biocide article | |
IL179919A0 (en) | Neural stem cells, compositions containing the same and methods for promoting the division thereof | |
EP1492160A4 (en) | EVAPORATOR, MISCELLANEOUS, THESE USES AND EVAPORATING METHOD | |
AU2006321904A8 (en) | 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors | |
IL169318A0 (en) | Pyrimidines, methods for the production thereof, and use thereof | |
WO2006133055A3 (en) | Method and composition for increasing the alkalinity of the body | |
TW200635941A (en) | Chemical compounds | |
MX263097B (es) | Inhibidores de entrada a moleculas pequenas. | |
GB0417803D0 (en) | Algorithmic trading | |
SG155165A1 (en) | Crystalline and amorphous forms of smilagenin | |
WO2008021518A3 (en) | Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride | |
IL181313A0 (en) | 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same | |
WO2003099783A3 (en) | Tropane compounds | |
AU2003258616A1 (en) | Device for turning flat mailing items through 900 | |
AP2244A (en) | Topical methadone compositions and methods for using the same. | |
GB0514628D0 (en) | 2,6,8-trisubstituted purines and their different uses | |
CA118270S (en) | Wrench set case | |
AU2005904583A0 (en) | Reminder Device | |
ZA200404236B (en) | Shears or the like. | |
AU2005904753A0 (en) | Male contraceptive device | |
GB0413845D0 (en) | The treatment of emesis | |
GB0317135D0 (en) | The treatment of emesis |